Immunovaccine’s Ovarian Cancer Study Shows Promising Data
Do Customers Care About Consumer Holidays Anymore?
Rebalancing Your Portfolio? Congratulations, You're an Active Investor...
Taranis Resources (TRO:CA) Sees Big Things for Its Thor Deposit
Dividend Paying Stocks – Part Of The Solution?
Equities.com speaks with James Sapirstein, CEO of ContraVir Pharmaceuticals Inc. (CTRV) at the Rodman & Renshaw Conference 2015.
You have to be logged in to leave a comment.
I'm sorry, but in order to complete what you're trying to do, you must be logged in.
© 2017 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).